UNSPSC 51282941: Prulifloxacin

This classification denotes a quinolone antibiotic with the molecular formula C21H20FN3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J42298IESW, chemically known as 1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo- but generally known as prulifloxacin, which bears US NIH Compound Identifier 65947. European Medicines Agency schedules Prulifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10156MIG.

UNSPSC 51282941 Prulifloxacin is a Commodity code for a specific fluoroquinolone antibiotic, but recent state and local solicitation activity under this code shows minimal direct purchasing of prulifloxacin itself. Instead, state and local health departments and county health agencies are procuring related antimicrobial pharmaceuticals and public health commodities — including broad-spectrum fluoroquinolone antibiotics, opioid-antagonist drugs, and drug deactivation systems — through piggyback contracts and competitive bidding processes tied to cooperative purchasing vehicles such as MMCAP Infuse. The work involves warehouse procurement and quarterly distribution of pharmaceuticals to health department facilities and community health centers, with vendors managing logistics, expiration tracking, and compliance with federal and state regulatory requirements.

Illinois Department of Public Health and Seminole County, Florida represent the issuing-body mix, with activity spanning state health departments and county health agencies focused on public health supply chains. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 through MMCAP Infuse for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets across a 12-month initial term with renewal options for years 2 and 3 via Invitation for Bid (IFB 26482DPHPREPDB53392). Seminole County, Florida issued an IFB (IFB60459723LAS) with a response deadline of July 26, 2023 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for delivery to the Seminole County Community Health Building, with all shipping and delivery costs incumbent on the vendor and a two-year initial contract term with one-year renewal option.